Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

9
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation article
FasterCures Statement of Support for 21st Century Cures 2.0 Legislation
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutt
ing-edge biomedical innovations to patients.
Nov 16, 2021
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development report
The Promise of Multi-Cancer Early Detection Technologies in Encouraging Research and Development
New blood-based technologies, known as multi-cancer early detection (MCED) tests, are entering&nbsp
;the market and can identify multiple cancers early and simultaneously.
Nov 3, 2021
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners report
Advancing Models of Patient Engagement: Patient Organizations as Research and Data Partners
FasterCures, alongside other patient-focused advocacy organizations, has long worked with stakehold
ers such as product developers and regulators to define and implement the “how to” of patient
Oct 19, 2020
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap report
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical i
nnovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not think possible.
Nov 19, 2021
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem report
Achieving Health Equity: A Multi-Stakeholder Action Plan to Address Diversity across the Clinical Trials Enterprise and the Biomedical Research Ecosystem
Clinical trials have been used for decades as the primary way by which researchers determine if a n
ew treatment is safe and effective for human use.
Nov 18, 2021
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information panel
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
This session will open with a conversation with Stephen Hahn, Commissioner, US Food and Drug Adm
inistration, followed by a panel discussion.
Oct 21, 2020
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information video
Part 1: A Conversation with FDA Commissioner Stephen Hahn | Part 2: Health Innovation: Improving Patient Access and Information
October 21 at 11:45 am PDT/2:45 pm EDT   This session will open with a conversation with St
ephen Hahn, Commissioner, US Food and Drug Administration, followed by a panel discussion.
Oct 8, 2020
Experts Discuss Long-Term Data Collection for Cell and Gene Therapies article
Experts Discuss Long-Term Data Collection for Cell and Gene Therapies
.bubble-images, .bubble-images img { border-radius: 50%; } FasterCures Webinar Brings Together Exp
erts to Discuss Long-Term Data Collection for Cell and Gene Therapies In a webinar on September 23, 2020,
Oct 14, 2020
Cures for Life Quarterly article
Cures for Life Quarterly
In this Cures for Life Issue Featured Story Regulatory Coverage and Reimbursement Policy FasterCure
s’ Resources
Oct 14, 2020